78 related articles for article (PubMed ID: 8750280)
1. Severe migratory polyarthritis following in vivo CAMPATH-1G.
Varadi G; Or R; Rund D; Orbach H; Slavin S; Nagler A
Bone Marrow Transplant; 1995 Dec; 16(6):843-5. PubMed ID: 8750280
[TBL] [Abstract][Full Text] [Related]
2. Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.
Condiotti R; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):713-20. PubMed ID: 8899185
[TBL] [Abstract][Full Text] [Related]
3. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
[TBL] [Abstract][Full Text] [Related]
4. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
5. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Naparstek E; Delukina M; Or R; Nagler A; Kapelushnik J; Varadi G; Strauss N; Cividalli G; Aker M; Brautbar C; Waldmann H; Hale G; Slavin S
Exp Hematol; 1999 Jul; 27(7):1210-8. PubMed ID: 10390197
[TBL] [Abstract][Full Text] [Related]
7. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
[TBL] [Abstract][Full Text] [Related]
8. T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
Jacobs P; Wood L; Fullard L; Waldmann H; Hale G
Bone Marrow Transplant; 1994 Jun; 13(6):763-9. PubMed ID: 7920312
[TBL] [Abstract][Full Text] [Related]
9. Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Cobbold SP; Hale G; Clark MR; Waldmann H
Prog Clin Biol Res; 1990; 333():139-51; discussion 152-4. PubMed ID: 2308978
[TBL] [Abstract][Full Text] [Related]
10. CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Hale G; Waldmann H
J Hematother; 1994; 3(1):15-31. PubMed ID: 7922004
[TBL] [Abstract][Full Text] [Related]
11. Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection.
Or R; Mehta J; Kapelushnik J; Aker M; Naparstek E; Nagler A; Cividalli G; Slavin S
Bone Marrow Transplant; 1994 Jan; 13(1):97-9. PubMed ID: 8019459
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells.
Nagler A; Condiotti R; Lubina A; Deutsch VR
Bone Marrow Transplant; 1997 Oct; 20(7):525-31. PubMed ID: 9337053
[TBL] [Abstract][Full Text] [Related]
13. In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
Willemze R; Richel DJ; Falkenburg JH; Hale G; Waldmann H; Zwaan FE; Fibbe WE
Bone Marrow Transplant; 1992 Apr; 9(4):255-61. PubMed ID: 1600413
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Hale G; Slavin S; Goldman JM; Mackinnon S; Giralt S; Waldmann H
Bone Marrow Transplant; 2002 Dec; 30(12):797-804. PubMed ID: 12476271
[TBL] [Abstract][Full Text] [Related]
15. In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Bunjes D; Hertenstein B; Wiesneth M; Stefanic M; Novotny J; Duncker C; Heit W; Arnold R; Heimpel H
Bone Marrow Transplant; 1995 Apr; 15(4):563-8. PubMed ID: 7655382
[TBL] [Abstract][Full Text] [Related]
16. Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.
Klangsinsirikul P; Carter GI; Byrne JL; Hale G; Russell NH
Blood; 2002 Apr; 99(7):2586-91. PubMed ID: 11895797
[TBL] [Abstract][Full Text] [Related]
17. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET
Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200
[TBL] [Abstract][Full Text] [Related]
18. Campath-1G. Campath IgG, Campath-1-IgG antibody.
Drugs R D; 1999 Jan; 1(1):71-2. PubMed ID: 10565991
[No Abstract] [Full Text] [Related]
19. A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
Shore T; Harpel J; Schuster MW; Roboz GJ; Leonard JP; Coleman M; Feldman EJ; Silver RT
Biol Blood Marrow Transplant; 2006 Aug; 12(8):868-75. PubMed ID: 16864057
[TBL] [Abstract][Full Text] [Related]
20. Ischaemic retinopathy occurring in patients receiving bone marrow allografts and campath-1G: a clinicopathological study.
Webster AR; Anderson JR; Richards EM; Moore AT
Br J Ophthalmol; 1995 Jul; 79(7):687-91. PubMed ID: 7662637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
